These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 22137045)

  • 1. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.
    Prvulovic D; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):517-9. PubMed ID: 22137044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention trials in Alzheimer's disease: an EU-US task force report.
    Vellas B; Aisen PS; Sampaio C; Carrillo M; Scheltens P; Scherrer B; Frisoni GB; Weiner M; Schneider L; Gauthier S; Gispen-de Wied CC; Hendrix S; Feldman H; Cedarbaum J; Petersen R; Siemers E; Andrieu S; Prvulovic D; Touchon J; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):594-600. PubMed ID: 21925234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular biomarkers for early detection of Alzheimer's disease.
    Frost S; Martins RN; Kanagasingam Y
    J Alzheimers Dis; 2010; 22(1):1-16. PubMed ID: 20847434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The world of dementia beyond 2020.
    Brodaty H; Breteler MM; Dekosky ST; Dorenlot P; Fratiglioni L; Hock C; Kenigsberg PA; Scheltens P; De Strooper B
    J Am Geriatr Soc; 2011 May; 59(5):923-7. PubMed ID: 21488846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease. AMA Council on Scientific Affairs Reference Committee D.
    J Okla State Med Assoc; 1998 Aug; 91(5):298-306. PubMed ID: 9714972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on clinical proteomics in Alzheimer's research.
    Korolainen MA; Nyman TA; Aittokallio T; Pirttilä T
    J Neurochem; 2010 Mar; 112(6):1386-414. PubMed ID: 20050976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease: immunity and diagnosis].
    Herrera-Rivero M; Hernández-Aguilar ME; Manzo J; Aranda-Abreu GE
    Rev Neurol; 2010 Aug; 51(3):153-64. PubMed ID: 20645266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease.
    Alzheimer's Association Expert Advisory Workgroup on NAPA
    Alzheimers Dement; 2012 Jul; 8(4):357-71. PubMed ID: 22748940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of Alzheimer's disease--an update.
    Srinivas P
    Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research and standardization in Alzheimer's trials: reaching international consensus.
    Carrillo MC; Rowe CC; Szoeke C; Masters CL; Ames D; O'Meara T; Macaulay SL; Milner A; Ellis KA; Maruff P; Rainey-Smith SR; Martins RN; Bain LJ; Head RJ;
    Alzheimers Dement; 2013 Mar; 9(2):160-8. PubMed ID: 23266004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.